Among those with LV dysfunction, transfemoral TAVR was linked to better improvement in LVEF (difference = 4.04%; 95% CI, 2.39-5.69) and 6-minute walk distance (difference = 45.1 m; 95% CI, 18.4-71 ...

While experience with transapical TAVR has grown in recent years, the lessons learned have failed to translate into improved quality of life (QoL) at 12 months compared with what was seen in the ...

At 1 year, transapical TAVR carried higher risk of mortality compared with transvascular TAVR, even after adjusting for confounders (OR 1.398; 95% CI 1.217-1.606). Stroke and TIA remained equivalent ...

Transcatheter aortic valve replacement is safe, ... Both transfemoral and transapical approaches to TAVR appear to be safe and effective for treatment of aortic stenosis in select patients age 90 ...

In patients with severe symptomatic aortic stenosis treated with transcatheter aortic valve replacement, transfemoral and transaortic access routes appear to yield comparable rates of 30-day ...

The transfemoral approach was used in 72.9% of the cohort, the transapical approach in 17.5%, and subclavian in 5.8% of the group. As judged by a lowered mean gradient, 97% of the procedures were ...

Patients assigned to TAVR were treated by either the transfemoral or transapical approach on the basis of whether peripheral arteries could accommodate the large sheaths required (22 French for ...

The first trial will study alternatives to transfemoral approaches in 1,000 patients considered ineligible for aortic valve surgery. "Since transapical and transaortic [approaches] were not ...

Select patients age 90 years and older with aortic stenosis (AS) can benefit from a relatively new, minimally invasive surgery for aortic valve replacement, according to an article in the ...

“Current results for transcatheter aortic valve replacement via the transapical approach, compared with surgical aortic valve replacement, are unattractive from a health economic perspective ...